Midnolin is a novel regulator of parkin expression and is associated with Parkinson's Disease
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 successful.
Replications
- Midnolin is a confirmed genetic risk factor for Parkinson's disease, Obara et al. (2019). Outcome recorded: successful.
We showed the strong genetic association of MIDN with PD development in a British population and in a Japanese population, suggesting MIDN is a confirmed and universal genetic risk factor for PD.
View paper
Other studies in the atlas
Failed replications · Successful replications · All browse pages